Eiger BioPharmaceuticals Inc
NASDAQ:EIGR

Watchlist Manager
Eiger BioPharmaceuticals Inc Logo
Eiger BioPharmaceuticals Inc
NASDAQ:EIGR
Watchlist
Price: 1.73 USD -33.46% Market Closed
Updated: May 25, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

38.8m
-30%
Assets
Growth Rates:
1 Year
-68%
3 Years
-73%
5 Years
-62%
7 Years
-36%
10 Years
+83%
53.3m
-7%
Liabilities
Growth Rates:
1 Year
-18%
3 Years
+10%
5 Years
+48%
7 Years
+166%
10 Years
+707%
-14.5m
-804%
Equity
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Eiger BioPharmaceuticals Inc

38.8m
Assets
53.3m
Liabilities
38.8m
Assets
53.3m
Liabilities
Current Assets 37.8m
Cash & Short-Term Investments 25.4m
Receivables 1.7m
Other Current Assets 10.7m
Non-Current Assets 987k
PP&E 627k
Other Non-Current Assets 360k
Current Liabilities 53.3m
Accounts Payable 2.1m
Accrued Liabilities 10.1m
Other Current Liabilities 41.1m

Balance Sheet
Eiger BioPharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
14
5
28
32
61
39
29
22
26
25
Cash Equivalents
14
5
28
32
61
39
29
22
26
25
Short-Term Investments
71
0
32
10
39
56
100
67
73
0
Total Receivables
0
0
0
0
0
0
0
3
2
2
Accounts Receivables
0
0
0
0
0
0
0
3
2
2
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
3
3
2
Other Current Assets
3
1
1
1
2
5
9
9
14
9
Total Current Assets
88
6
61
43
102
100
138
103
118
38
PP&E Net
1
0
0
0
0
2
2
1
1
1
PP&E Gross
1
0
0
0
0
2
2
1
1
1
Accumulated Depreciation
0
0
0
0
0
0
0
1
1
1
Long-Term Investments
0
0
0
0
0
0
0
17
0
0
Other Long-Term Assets
0
0
0
0
0
3
4
5
1
0
Total Assets
89
N/A
6
-94%
61
+984%
43
-29%
102
+139%
105
+3%
144
+37%
126
-12%
120
-5%
39
-68%
Liabilities
Accounts Payable
3
2
3
3
6
6
5
8
9
2
Accrued Liabilities
3
1
3
2
4
11
12
14
16
10
Short-Term Debt
0
5
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
2
0
0
0
8
0
41
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
7
8
5
7
10
17
17
30
25
53
Long-Term Debt
10
0
15
13
26
30
31
24
40
0
Other Liabilities
0
2
0
0
0
1
1
0
0
0
Total Liabilities
17
N/A
11
-37%
20
+87%
20
+2%
36
+76%
49
+36%
49
0%
54
+11%
65
+20%
53
-18%
Equity
Common Stock
0
23
0
0
0
0
0
0
0
0
Retained Earnings
146
29
76
119
171
241
307
340
437
512
Additional Paid In Capital
219
2
117
141
238
298
402
413
493
498
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
72
N/A
5
N/A
41
N/A
23
-45%
67
+196%
57
-15%
95
+68%
72
-24%
55
-24%
14
N/A
Total Liabilities & Equity
89
N/A
6
-94%
61
+984%
43
-29%
102
+139%
105
+3%
144
+37%
126
-12%
120
-5%
39
-68%
Shares Outstanding
Common Shares Outstanding
2
0
8
11
19
25
34
35
44
1

See Also

Summary
EIGR intrinsic value, competitors valuation, and company profile.
DCF Valuation
EIGR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EIGR stock valuation using valuation multiples.
Wall Street Estimates
EIGR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EIGR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 140,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.